These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1140 related items for PubMed ID: 6577431

  • 1. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM, Limbird LE.
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [Abstract] [Full Text] [Related]

  • 2. Inhibitors of Na+/H+ exchange block stimulus-provoked arachidonic acid release in human platelets. Selective effects on platelet activation by epinephrine, ADP, and lower concentrations of thrombin.
    Sweatt JD, Johnson SL, Cragoe EJ, Limbird LE.
    J Biol Chem; 1985 Oct 25; 260(24):12910-9. PubMed ID: 2997148
    [Abstract] [Full Text] [Related]

  • 3. Inhibitors of Na+/H+ exchange block epinephrine- and ADP-induced stimulation of human platelet phospholipase C by blockade of arachidonic acid release at a prior step.
    Sweatt JD, Blair IA, Cragoe EJ, Limbird LE.
    J Biol Chem; 1986 Jul 05; 261(19):8660-6. PubMed ID: 3013858
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S, Joseph S, Kakkar VV.
    Biochim Biophys Acta; 1987 Mar 11; 927(3):429-36. PubMed ID: 3101746
    [Abstract] [Full Text] [Related]

  • 6. The influence of Na+ on the alpha 2-adrenergic receptor system of human platelets. A method for removal of extraplatelet Na+. Effect of Na+ removal on aggregation, secretion, and cAMP accumulation.
    Connolly TM, Limbird LE.
    J Biol Chem; 1983 Mar 25; 258(6):3907-12. PubMed ID: 6300061
    [No Abstract] [Full Text] [Related]

  • 7. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May 25; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 8. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar, Anwer K.
    Thromb Res; 1986 Feb 15; 41(4):555-66. PubMed ID: 3961734
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
    Le Breton GC, Venton DL, Enke SE, Halushka PV.
    Proc Natl Acad Sci U S A; 1979 Aug 15; 76(8):4097-101. PubMed ID: 291066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets.
    Knezevic I, Dieter JP, Le Breton GC.
    J Pharmacol Exp Ther; 1992 Mar 15; 260(3):947-55. PubMed ID: 1545407
    [Abstract] [Full Text] [Related]

  • 14. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI.
    Am J Hematol; 1984 May 15; 16(4):335-45. PubMed ID: 6326566
    [Abstract] [Full Text] [Related]

  • 15. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 16. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP.
    Am J Physiol; 1988 Dec 15; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [Abstract] [Full Text] [Related]

  • 17. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 15; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
    White JG, Rao GH, Gerrard JM.
    Am J Pathol; 1977 Aug 15; 88(2):387-402. PubMed ID: 879276
    [Abstract] [Full Text] [Related]

  • 20. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K, Huzoor-Akbar.
    Thromb Res; 1985 May 15; 38(4):361-74. PubMed ID: 2990062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.